Live feed08:00:00·186dPRReleasevia QuantisnowFortress Biotech and Cyprium Therapeutics Announce FDA Acceptance of CUTX-101 NDA ResubmissionByQuantisnow·Wall Street's wire, on your screen.FBIO· Fortress Biotech Inc.Health Care